ConductScience.org, home

Paper7053285

The 24-hour ambulatory blood pressure profile with verapamil.

Gould BA and 4 others. Circulation, 1982. Cited by 155 papers, by iCite.

Cite this record

ConductScience Library. The 24-hour ambulatory blood pressure profile with verapamil. Papers, record 7053285. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7053285

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The 24-hour ambulatory blood pressure profile with verapamil.
PubMed
Journal
Circulation
PubMed
Year
1982
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
155
iCite
Relative citation ratio, by iCite
9.11
iCite
Revised in PubMed
2019-06-23
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gould BAB A
2Mann SS
3Kieso HH
4Subramanian VBV B
5Raftery EBE B

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HypertensionMajor topic
VerapamilMajor topic
Adult
Blood Pressure
Female
Humans
Male
Middle Aged
Physical Exertion

Source PubMed

Download CSV of topics

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 155 citations.

PMIDTitleJournalYearIn PapersSource
27531061Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein.Biochem Pharmacol2016https://conductscience.org/library/papers/27531061PubMed
26823559Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein.Biosci Rep2016https://conductscience.org/library/papers/26823559PubMed
20166433Effects of simvastatin on the pharmacokinetics of verapamil and its main metabolite, norverapamil, in rats.Eur J Drug Metab Pharmacokinet2009https://conductscience.org/library/papers/20166433PubMed
20012601Pharmacokinetic interaction between oral lovastatin and verapamil in healthy subjects: role of P-glycoprotein inhibition by lovastatin.Eur J Clin Pharmacol2010https://conductscience.org/library/papers/20012601PubMed
18193210Drug interaction between oral atorvastatin and verapamil in healthy subjects: effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil.Eur J Clin Pharmacol2008https://conductscience.org/library/papers/18193210PubMed
6884408The effects of oxprenolol on ambulatory intra-arterial blood pressure in essential hypertension.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6884408PubMed
6831336Calcium blockers for cardiac disease: therapeutic implications.Can Med Assoc J1983https://conductscience.org/library/papers/6831336PubMed
6529523Effect of a new calcium antagonist, tiapamil, in hypertension of the elderly.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6529523PubMed
6412795Effect on intra-arterial blood pressure of slow release metoprolol combined with placebo or chlorthalidone.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6412795PubMed
6362951Clinical pharmacokinetics of verapamil.Clin Pharmacokinet1984https://conductscience.org/library/papers/6362951PubMed
6339198Calcium antagonists. Clinical use in the treatment of systemic hypertension.Drugs1983https://conductscience.org/library/papers/6339198PubMed
6125200A study of nadolol to determine its effect on ambulatory blood pressure over 24 hours, and during exercise testing.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6125200PubMed
3931832Calcium channel blocking agents and the heart.Br Med J (Clin Res Ed)1985https://conductscience.org/library/papers/3931832PubMed
3912182Felodipine in hypertension.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3912182PubMed
3803414Pharmacokinetics of verapamil in patients with hypertension.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3803414PubMed
3743614Tiapamil, a new calcium channel blocking agent for the treatment of effort induced chronic stable angina pectoris.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3743614PubMed
3653222A comparison of nine calcium ion antagonists and propranolol: exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris.Eur J Clin Pharmacol1987https://conductscience.org/library/papers/3653222PubMed
3539623Sustained release verapamil in hypertension. Results from a noninvasive ambulatory blood pressure monitoring and a clinical study.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3539623PubMed
3534840Calcium antagonists and chronic cardiac failure.Postgrad Med J1986https://conductscience.org/library/papers/3534840PubMed
3154631Twenty-four-hour blood pressure monitoring after a single dose of sustained-release verapamil.Cardiovasc Drugs Ther1988https://conductscience.org/library/papers/3154631PubMed

See all 25 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7053285

GET https://conductscience.org/api/papers/v1/7053285/cited_by?page=2